NewsReutersMay 8, 2026United States
President Trump Weighs Replacing FDA Commissioner Dr. Marty Makary
President Donald Trump is reportedly considering the removal of FDA Commissioner Dr. Marty Makary following internal frustration over agency performance and delayed policy reviews. While no final decision has been made, the potential move follows months of controversy regarding abortion pill regulations, drug approval rejections, and vaping policy.
Read the full story at ReutersWhy It Matters
The potential replacement of the FDA commissioner could shift the agency's regulatory approach to drug approvals, abortion medication access, and nicotine product oversight, impacting both public health policy and pharmaceutical industry operations.
Key Facts
Each fact below is taken from the article. Click one to see the exact passage.
Who's Mentioned
organizationModerna“Drugmaker whose mRNA flu vaccine application was initially declined then reconsi”personKush Desai“White House spokesman.”personMarty Makary“Current FDA Commissioner whose tenure is under review.”organizationUniQure“Drugmaker whose Huntington's disease gene therapy application was rejected.”personRobert F. Kennedy Jr.“Health Secretary and political ally of Makary.”organizationFood and Drug Administration“Federal agency responsible for regulating food, drugs, and medical devices.”personDonald Trump“President of the United States considering the firing of the FDA Commissioner.”personVinay Prasad“Former FDA official who faced ouster over drug review decisions.”